News Finding: If the growth resists neoadjuvant therapy, it is more likely to spread to other parts of the body.
Paper Finding: 1g ) and found no obvious differences between PTX-EVs and CREMO-EVs.
News Context: But the treatment does not always shrink tumours. If the growth resists neoadjuvant therapy, it is more likely to spread to other parts of the body. Related Slideshow: 16 Unexpected Cancer Symptoms Every Woman Should Know (provided by Health.com)
  
  'It seems that loading of annexin-A6 into exosomes is significantly enhanced in response to chemotherapy,' study author and postdoctoral researcher Professor Ioanna Keklikoglou said.
Paper Context: 1d ), NTA ( Supplementary Fig. 1g ) and found no obvious differences between PTX-EVs and CREMO-EVs. Similar to the results obtained with 4T1 cells, PTX-EVs increased the number of metastatic nodules in this MMTV-PyMT-based lung colonization assay (Fig.